S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6994 +0.01%
PRE-MKT · 05:45 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead
SA
INSIDER · RVMD · Revolution Medicines, Inc. · CHIEF DEVELOPMENT OFFICER

Sandler Alan B.

Every open-market transaction filed under this name, Sep 16 to Sep 29.

Filings
6
0 buys · 6 sells
Bought
—
open market, at cost
Sold
$1.3M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 29RVMDRevolution Medicines, Inc.Chief Development OfficerSell301$204.72$62K—
Sep 29RVMDRevolution Medicines, Inc.Chief Development OfficerSell1,199$203.91$244K—
Sep 29RVMDRevolution Medicines, Inc.Chief Development OfficerSell1,000$202.81$203K—
Sep 29RVMDRevolution Medicines, Inc.Chief Development OfficerSell1,609$201.72$325K—
Sep 29RVMDRevolution Medicines, Inc.Chief Development OfficerSell2,200$200.82$442K—
Sep 16RVMDRevolution Medicines, Inc.Chief Development OfficerSell336$199.30$67K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.